Search

Displaying results 6341 - 6350 of 9670 in total
  1. Drug

    ODN M362

    go.drugbank.com/drugs/DB16485
    Experimental

  2. Drug

    R-851

    go.drugbank.com/drugs/DB05747
    Experimental

    R-851 is part of the family of immune response modifier (IRM) and it acts in a novel way to stimulate the human body's immnune system to attack virus-infected cells and tumor cells. … It is expected to be topical treatment for cervical displasia and cervical high-risk human papillomavirus (HPV), the sexually transmitted virus that causes most cases of cervical cancer.

  3. Drug

    Garden snail mucin

    go.drugbank.com/drugs/DB14244
    Investigational

    It is not an approved drug.

  4. Drug

    Marine collagen, soluble

    go.drugbank.com/drugs/DB14246
    Investigational

    It is not an approved drug.

  5. Drug

    Argan oil

    go.drugbank.com/drugs/DB14310
    Investigational

    It is not an approved drug.

  6. Drug

    Macadamia oil

    go.drugbank.com/drugs/DB14330
    Investigational

    It is not an approved drug.

  7. Drug

    Tribulus terrestris

    go.drugbank.com/drugs/DB14358
    Investigational

    It is not an approved drug.

  8. Drug

    Fluorine F-18

    go.drugbank.com/drugs/DB13134
    Investigational

    Fluorine-18 is under investigation in clinical trial NCT00870974 (A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions).

  9. Drug

    QR-313

    go.drugbank.com/drugs/DB17867
    Investigational

    It is being investigated for the treatment of dystrophic epidermolysis bullosa.[A259867]

  10. Drug

    Onvitrelin ucalontide

    go.drugbank.com/drugs/DB19183
    Investigational

    Onvitrelin ucalontide is under investigation in clinical trial NCT01485848 (EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer).

    Synonyms: Ep-100 (peptide), Membrane-disrupting peptide ep-100